Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.
Ipsen
Ipsen
Roswell Park Cancer Institute
Nektar Therapeutics
West China Hospital
Assistance Publique - Hôpitaux de Paris
Georgetown University
Sun Yat-sen University
HiberCell, Inc.
Georgetown University
University of Illinois at Chicago
Radboud University Medical Center